Tag: Asterion Cannabis Inc.

April 9, 2020

Asterion Appoints Amy Stephenson as Chief Investment Officer

Asterion Cannabis announces the appointment of Amy Stephenson, MBA, CFA, CPA, CMA, as Chief Investment Officer.
March 31, 2020

Asterion Signs DAA for $400 Million

Asterion Signs Exclusive Definitive Association Agreement for $400 Million Financing, Development and Construction
March 9, 2020

Asterion Cannabis to Participate in the 32nd Annual ROTH Conference

Asterion Cannabis Inc. is pleased to announce that it will participate in the 32nd Annual ROTH Conference taking place in Orange County,...
February 4, 2020

Asterion Cannabis Officially Listed on the Australian Department of Health and Office of Drug Control

Asterion Cannabis is listed as a medicinal cannabis manufacturer and supplier on the Australian government's Department of Health and Office of...
January 27, 2020

Asterion Cannabis Announces Election of New Director

Asterion is pleased to announce the voting results from the Company's 2020 annual general meeting of shareholders held on Friday,...
December 23, 2019

Asterion Awarded Medicinal Cannabis Licences from the Australian Office of Drug Control

Asterion Cannabis Inc. announces that its subsidiary has received its licences for the cultivation, manufacturing and research of medicinal cannabis.
December 8, 2019

Asterion Cannabis CEO: Major Project Status Fast Tracking Australian Operations

Asterion Cannabis Chairman and CEO Stephen Van Deventer says that the government’s support for the company's project has enabled a...